Venous Disease - General

ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
CRT 25: The PEERLESS Contraindication Cohort

Stefan Stortecky

Watch time: 7m 7s
CRT 2025 Meeting Unveils its Late-Breaking Scientific Programme

CRT 2025

LINC 25: The GRIFFIN Study

Tatsuya Nakama

Watch time: 11m 59s
Why are the PEERLESS Outcomes impactful?

Jay Giri

Watch time: 12m 25s

Felix Mahfoud, Ingo Ahrens, Thomas Cuisset, et al

TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s

Nazli Okumus , Ashley Park , Eugene Yuridistky , et al

Read time: 29m 12s

Broadcast

Vascular Disease and Surgery
Multidisciplinary Approaches to Improve Pulmonary Embolism (PE) Management

Felix Mahfoud, Ingo Ahrens, Thomas Cuisset, et al

Watch time: 1h 3m 45s

Thomas Tu, Jay Giri, Felix Mahfoud, et al

Watch time: 52m 30s
Immediate Impact

Michael Piorkowski, Pablo Salinas, Gregor Leibundgut, et al

Watch time: 1h 4m 51s
Patient Pathway

Maximilian de Bucourt, Ana Viana Tejedor, Ole Jørgen Grøtta, et al

Watch time: 57m 52s

Broadcast

Vascular Disease and Surgery
Multidisciplinary Approaches to Improve Pulmonary Embolism (PE) Management

Felix Mahfoud, Ingo Ahrens, Thomas Cuisset, et al

Watch time: 1h 3m 45s

Michael Lee , Jeremy Kong

Read time: 15m

Han Naung Tun , May Thu Kyaw , Erik Rafflenbeul , et al

Read time: 20m 11s

Josip Katic , Josip A Borovac

Read time: 18m

Felix Mahfoud, Ingo Ahrens, Thomas Cuisset, et al

Alessandro Cannavale , Mariangela Santoni , Fabrizio Fanelli , et al

Read time: 13m

Nazli Okumus , Ashley Park , Eugene Yuridistky , et al

Read time: 29m 12s
AHA 21: AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism

Jeffrey Weitz

Watch time: 7m 58s

Pandanaboyana Sanjay , Mike H Lewis

Read time: 5m 8s
ACC 22: Mavacamten in Patients with Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Milind Y Desai

Watch time: 9m 38s

Krystal Dinh , Andrew Ying , Rafid Al-Asady , et al

Read time: 8m 40s

Silvio Leal

Watch time: 50s

Media

ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
CRT 25: The PEERLESS Contraindication Cohort

Stefan Stortecky

Watch time: 7m 7s
LINC 25: The GRIFFIN Study

Tatsuya Nakama

Watch time: 11m 59s
ACC 22: Mavacamten in Patients with Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Milind Y Desai

Watch time: 9m 38s
ESC 22: COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts

David Berg

Watch time: 4m 51s
ACC 22: Results from the POISE-3 Trial

Philip J Devereaux

Watch time: 4m 22s
ACC 22: Results from the POISE-3 Trial

Maura Marcucci

Watch time: 4m 48s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly

Watch time: 4m 59s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes

Watch time: 3m 57s
TCT 22: FLASH Trial: US Outcomes of the FlowTriever for PE

Catalin Toma

Watch time: 4m 10s
ESC 23: The ONCO DVT Study

Yugo Yamashita

Watch time: 4m 8s

Broadcast

Vascular Disease and Surgery
Multidisciplinary Approaches to Improve Pulmonary Embolism (PE) Management

Felix Mahfoud, Ingo Ahrens, Thomas Cuisset, et al

Watch time: 1h 3m 45s

Articles

Management of Venous Thromboembolism

Nazli Okumus

,

Ashley Park

,

Eugene Yuridistky

,

James M Horowitz

,

Michael A Solomon

,

Published:

27 November 2024

Citation:

US Cardiology Review 2024;18:e21.

DOI:

https://doi.org/10.15420/usc.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1393
  • Downloads: Downloads 108
  • Read time: 29m 12s

Persistent LA/LAA Thrombus in Patients on Chronic Anticoagulation

Josip Katic

,

Josip A Borovac

,

Published:

15 April 2023

Citation:

Cardiac Failure Review 2023;9:e05.

DOI:

https://doi.org/10.15420/cfr.2022.28
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4509
  • Downloads: Downloads 165
  • Citations: 6
  • Read time: 18m

Role of Newer Oral Anticoagulants for Post-operative Prophylaxis

Han Naung Tun

,

May Thu Kyaw

,

Erik Rafflenbeul

,

Xiuhtlaulli López Suástegui

,

Published:

13 May 2022

Citation:

European Cardiology Review 2022;17:e11.

DOI:

https://doi.org/10.15420/ecr.2021.55
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5006
  • Downloads: Downloads 368
  • Citations: 7
  • Read time: 20m 11s

Endovascular Treatment of a Large Iatrogenic Popliteal Arteriovenous Fistula

Krystal Dinh

,

Andrew Ying

,

Rafid Al-Asady

,

Mauro Vicaretti

,

Published:

22 July 2021

Citation:

Interventional Cardiology Review 2021;16:e15.

DOI:

https://doi.org/10.15420/icr.2021.16.PO4
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 954
  • Downloads: Downloads 16
  • Read time: 8m 40s